Nautilus Biotechnolgy, Inc. (NAUT) Financials

NAUT Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 163.6 million 32.5 million
March 31, 2026 177.8 million 33.4 million
Dec. 31, 2025 191.1 million 34.1 million
Sept. 30, 2025 200.9 million 31.8 million

NAUT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -14.2 million 1.2 million
March 31, 2026 -13.6 million 1.4 million
Dec. 31, 2025 -12.6 million 1.5 million
Sept. 30, 2025 -11.5 million 1.5 million

NAUT Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 -14.5 million
March 31, 2026 -14.7 million
Dec. 31, 2025 -13.8 million
Sept. 30, 2025 -13.6 million

NAUT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 84.0 million - 27.8 million
March 31, 2026 95.9 million - 28.9 million
Dec. 31, 2025 103.4 million - 30.0 million
Sept. 30, 2025 131.4 million - 27.0 million

NAUT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 126.9 million
March 31, 2026 126.6 million
Dec. 31, 2025 126.3 million
Sept. 30, 2025 126.3 million

NAUT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 454000 9.6 million 7.5 million -
March 31, 2026 510000 9.4 million 5.3 million -
Dec. 31, 2025 244000 10.9 million 5.8 million -
Sept. 30, 2025 418000 9.6 million 5.9 million -

NAUT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 190000 -1.1 million
March 31, 2026 - 1.5 million
Dec. 31, 2025 - 1.6 million
Sept. 30, 2025 - 1.6 million

NAUT

Price: $0.85

52 week price:
0.62
4.31

Earnings Per Share: -0.45 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 189600

Market Capitalization: 112.8 million

Links: